Making the transition from oral to insulin therapy
- 31 May 2005
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 118 (5) , 14-20
- https://doi.org/10.1016/j.amjmed.2005.04.008
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 DiabetesDiabetes Care, 2005
- The Burden of Treatment Failure in Type 2 DiabetesDiabetes Care, 2004
- Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed DiabetesJAMA, 2004
- The Treat-to-Target TrialDiabetes Care, 2003
- Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.Diabetes Care, 2000
- Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.Diabetes Care, 1999
- Starting Insulin Therapy in Patients With Type 2 DiabetesPublished by American Medical Association (AMA) ,1997
- Modification of Postprandial Hyperglycemia With Insulin Lispro Improves Glucose Control in Patients With Type 2 DiabetesDiabetes Care, 1997
- Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea FailureDiabetes Care, 1995
- Insulin plus a Sulfonylurea Agent for Treating Type 2 DiabetesAnnals of Internal Medicine, 1991